These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25197640)

  • 1. Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.
    Yang X; Xu Y
    Biomed Res Int; 2014; 2014():371256. PubMed ID: 25197640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
    Park JS; Sue CM
    Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.
    Paisán-Ruiz C; Guevara R; Federoff M; Hanagasi H; Sina F; Elahi E; Schneider SA; Schwingenschuh P; Bajaj N; Emre M; Singleton AB; Hardy J; Bhatia KP; Brandner S; Lees AJ; Houlden H
    Mov Disord; 2010 Sep; 25(12):1791-800. PubMed ID: 20669327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis.
    Bras J; Verloes A; Schneider SA; Mole SE; Guerreiro RJ
    Hum Mol Genet; 2012 Jun; 21(12):2646-50. PubMed ID: 22388936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
    Park JS; Blair NF; Sue CM
    Mov Disord; 2015 May; 30(6):770-9. PubMed ID: 25900096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene.
    Radi E; Formichi P; Di Maio G; Battisti C; Federico A
    J Cell Mol Med; 2012 Aug; 16(8):1916-23. PubMed ID: 22117566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Parkinson-associated human P5B-ATPase ATP13A2 modifies lipid homeostasis.
    Marcos AL; Corradi GR; Mazzitelli LR; Casali CI; Fernández Tome MDC; Adamo HP; de Tezanos Pinto F
    Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182993. PubMed ID: 31132336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal Storage of Subunit c of Mitochondrial ATP Synthase in Brain-Specific Atp13a2-Deficient Mice.
    Sato S; Koike M; Funayama M; Ezaki J; Fukuda T; Ueno T; Uchiyama Y; Hattori N
    Am J Pathol; 2016 Dec; 186(12):3074-3082. PubMed ID: 27770614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove.
    Dehay B; Martinez-Vicente M; Ramirez A; Perier C; Klein C; Vila M; Bezard E
    Autophagy; 2012 Sep; 8(9):1389-91. PubMed ID: 22885599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits.
    Schultheis PJ; Fleming SM; Clippinger AK; Lewis J; Tsunemi T; Giasson B; Dickson DW; Mazzulli JR; Bardgett ME; Haik KL; Ekhator O; Chava AK; Howard J; Gannon M; Hoffman E; Chen Y; Prasad V; Linn SC; Tamargo RJ; Westbroek W; Sidransky E; Krainc D; Shull GE
    Hum Mol Genet; 2013 May; 22(10):2067-82. PubMed ID: 23393156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathologic Findings in a Patient With Juvenile-Onset Levodopa-Responsive Parkinsonism Due to
    Chien HF; Rodriguez RD; Bonifati V; Nitrini R; Pasqualucci CA; Gelpi E; Barbosa ER
    Neurology; 2021 Oct; 97(16):763-766. PubMed ID: 34475127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
    Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
    Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome.
    Pietrzak A; Badura-Stronka M; Kangas-Kontio T; Felczak P; Kozubski W; Latos-Bielenska A; Wierzba-Bobrowicz T; Florczak-Wyspianska J
    Folia Neuropathol; 2019; 57(3):285-294. PubMed ID: 31588715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers.
    Farias FH; Zeng R; Johnson GS; Wininger FA; Taylor JF; Schnabel RD; McKay SD; Sanders DN; Lohi H; Seppälä EH; Wade CM; Lindblad-Toh K; O'Brien DP; Katz ML
    Neurobiol Dis; 2011 Jun; 42(3):468-74. PubMed ID: 21362476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal defects in ATP13A2 and GBA associated familial Parkinson's disease.
    Sato S; Li Y; Hattori N
    J Neural Transm (Vienna); 2017 Nov; 124(11):1395-1400. PubMed ID: 28894968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP13A2 variability in Parkinson disease.
    Vilariño-Güell C; Soto AI; Lincoln SJ; Ben Yahmed S; Kefi M; Heckman MG; Hulihan MM; Chai H; Diehl NN; Amouri R; Rajput A; Mash DC; Dickson DW; Middleton LT; Gibson RA; Hentati F; Farrer MJ
    Hum Mutat; 2009 Mar; 30(3):406-10. PubMed ID: 19085912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity.
    Usenovic M; Tresse E; Mazzulli JR; Taylor JP; Krainc D
    J Neurosci; 2012 Mar; 32(12):4240-6. PubMed ID: 22442086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.